Lucy Scientific Discovery Inc. (LSDI)
Pre-market:
- Business Wire
Lucy Scientific Discovery Inc. Receives Nasdaq Notification of Non-Compliance with Listing Rule 5250(c)(1)
VANCOUVER, British Columbia, May 28, 2024--Lucy Scientific Discovery Inc. (NASDAQ: LSDI), a Company dedicated to advancing the understanding and applications of psychotropic medicines, improving mental health outcomes, and enhancing well-being for individuals worldwide, announces that it has a hearing scheduled for June 25, 2024 before a Nasdaq Hearings Panel (the "Panel") regarding its plan to regain compliance with Nasdaq Listing Rule 5550(b) (the "Stockholders’ Equity Rule").
- Market Exclusive
Weekly Roundup on the Cannabis Sector & Psychedelic Sector Week of May 26th
Key Takeaways; Cannabis Sector Agrify converted $13.8m debt to equity to regain Nasdaq compliance. Glass House Brands is seeking Canadian funding through shelf prospectus. TILT Holdings’ cannabis sales are stable despite vape supply disruptions, debt and stock dilution concern; analyst says. Key Takeaways; Psychedelic Sector Awakn recently concluded a feasibility study with Catalent Pharma. Lucy […]
- Business Wire
Lucy Scientific Discovery Inc. Announces 1-for-10 Reverse Stock Split to Regain Compliance with Nasdaq Minimum Bid Requirement
VANCOUVER, British Columbia, February 16, 2024--Lucy Scientific Discovery Inc. (NASDAQ: LSDI), a Company dedicated to advancing the understanding and applications of psychotropic medicines, improving mental health outcomes, and enhancing well-being for individuals worldwide announces that the Company will effect a one-for-ten (1-10) reverse split of its common shares. The Company is effecting the reverse split in an effort to regain compliance with the $1.00 minimum bid price required for contin
